CoChat

Steroid hormone profiling reveals altered adrenal androgen production in endometriosis

Open access

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index; 17 of the 20 sources its claims cite were checked for support.

Abstract

Objective: Endometriosis is a chronic, hormone-dependent condition affecting an estimated 190 million women worldwide. Our understanding of hormonal contributions to endometriosis pathophysiology is incomplete, hindering the identification of diagnostic biomarkers and novel therapeutic targets. Although the role of estrogens is well established, research on androgens in endometriosis is limited and the contribution of adrenal-derived 11-oxygenated androgens remains largely unknown. Methods: We performed steroid androgen profiling to measure androgen concentrations in serum from healthy controls and women with laparoscopically confirmed endometriosis. We found that women with endometriosis had a distinct hormone signature characterized by systemic differences in adrenal androgen concentrations and 11-ketotestosterone excess. Using metabolomic data, we generated statistical models that showed robust discrimination between healthy controls and women with endometriosis (AUC = 0.99; positive predictive power = 96.84%, negative predictive power = 92.86%) consistent with an endometriosis-specific signature. Data were partitioned into train and validation groups to assess diagnostic potential and a refined model identified >95% of endometriosis patients in a blinded sample set. Conclusions: Collectively, these data reframe endometriosis as an androgen-dependent disorder and highlight 11-oxygenated androgens as potential diagnostic biomarkers and future therapeutic targets.

Overview

CoChat Summary

TL;DR

Serum androgen profiling in women with laparoscopically confirmed endometriosis versus healthy controls identified a distinct hormone signature marked by altered adrenal androgen production and 11-ketotestosterone excess. Statistical models using androgen concentrations discriminated endometriosis with high accuracy, including >95% sensitivity in a blinded validation set.

Key findings

In serum from healthy controls (n = 57) and women with endometriosis (n = 159), DHEA, A4, and T were significantly elevated in endometriosis (P < .0001), while DHT did not differ; 11OHA4 and 11KA4 were decreased (P < .05 and P < .0001), and 11OHT and 11KT were increased (P < .0001).

  • Altered adrenal androgen metabolism was biased toward 11KT: ratios 11OHA4/A4, 11OHT/T, and 11KA4/11OHA4 were decreased, while 11KT/11OHT, 11OHT/11OHA4, and 11KT/11KA4 were increased (P < .0001).
  • The 11KT/11KA4 ratio gave the most robust single discrimination between controls and endometriosis (AUC 0.968, P < .001; sensitivity 92.36%, specificity 90.91%, likelihood ratio 10.16).
  • A multiple logistic regression model using androgen concentrations, age, and BMI achieved AUC 0.99 (P < .0001), positive predictive power 96.84%, and negative predictive power 92.86%; a refined model using BMI, 11OHA4, 11KA4, and 11KT identified >95% of endometriosis patients in a blinded validation set (sensitivity 95.65%; PPV 95.24%; NPV 94.74%).

Methods

Case-control serum steroid profiling: healthy controls (n = 57) and women with laparoscopically confirmed endometriosis (n = 159) were compared using LC-MS/MS to measure DHEA, A4, T, DHT, 11OHA4, 11OHT, 11KA4, and 11KT.

  • Analyses included Mann–Whitney U and Kruskal–Wallis tests, Pearson correlation matrices, product/substrate ratios as proxies for enzyme activity, ROC curve analysis, and multiple logistic regression.
  • For predictive modeling, data were partitioned into a training set (21 healthy controls and 21 endometriosis cases) and a blinded validation set (n = 138).

Limitations

The paper states that enzymatic activities were inferred from product/substrate ratios rather than measured directly, and that products can be metabolized further; the cells contributing to altered androgen metabolism are unknown.

  • The authors state that the study primarily included participants of European ethnicity and that larger, more representative cohorts are needed to assess generalizability across demographics and endometriosis subtypes.
  • The authors note a discrepancy with Mendelian randomization findings showing an inverse relationship between genetically predicted androgens and endometriosis risk; they attribute this to differences between point-of-sampling mass spectrometry and lifelong genetically predicted exposure, and call for integrated observational and genetic work to delineate causality.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1093/ejendo/lvag109

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1. Serum concentrations of classic and 11-oxygenated androgens are altered in women with endometriosis. Serum concentrations of DHEA, A4, T, 11OHA4, 11KA4, 11OHT, and 11KT were determined by LC-MS/MS. DHEA, A4, and T were significantly elevated in women with endometriosis (ENDO) compared with heathy controls (HCs; A-C). Concentrations of DHT did not differ between groups (D). 11-oxygenated androgen precursors, 11OHA4 (E) and 11KA4 (F), were decreased in ENDO, while potent 11-oxygenated androgens, 11OHT (G) and 11KT (H) were significantly elevated in ENDO. Patients with ENDO were stratified according to rASRM stage (I-P). DHEA and A4 were significantly elevated in Stage I, II, and IV endometriosis (I, J). T was elevated in all endometriosis stages (K), and DHT was significantly elevated in Stage I endometriosis (L). Concentrations of 11OHA4 did not significantly differ between groups (M) while 11KA4 was decreased in all stages (N). In contrast, 11OHT was significantly elevated in Stage I endometriosis (O) while 11KT was elevated in all endometriosis stages (P). Median serum steroid concentrations (25th-75th centile range; nmol L-1) for each stage (I). Error bars represent the SD of the mean. Dotted lines denote LLOQ for each analyte. Undetected steroids or those detected below LLOQ were replaced by 0.5×LLOQ for statistical purposes. Statistical comparison using Mann–Whitney U test or Kruskal–Wallis test with multiple comparisons. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001. ns, non-significant.
Figure 1. Serum concentrations of classic and 11-oxygenated androgens are altered in women with endometriosis. Serum concentrations of DHEA, A4, T, 11OHA4, 11KA4, 11OHT, and 11KT were determined by LC-MS/MS. DHEA, A4, and T were significantly elevated in women with endometriosis (ENDO) compared with heathy controls (HCs; A-C). Concentrations of DHT did not differ between groups (D). 11-oxygenated androgen precursors, 11OHA4 (E) and 11KA4 (F), were decreased in ENDO, while potent 11-oxygenated androgens, 11OHT (G) and 11KT (H) were significantly elevated in ENDO. Patients with ENDO were stratified according to rASRM stage (I-P). DHEA and A4 were significantly elevated in Stage I, II, and IV endometriosis (I, J). T was elevated in all endometriosis stages (K), and DHT was significantly elevated in Stage I endometriosis (L). Concentrations of 11OHA4 did not significantly differ between groups (M) while 11KA4 was decreased in all stages (N). In contrast, 11OHT was significantly elevated in Stage I endometriosis (O) while 11KT was elevated in all endometriosis stages (P). Median serum steroid concentrations (25th-75th centile range; nmol L-1) for each stage (I). Error bars represent the SD of the mean. Dotted lines denote LLOQ for each analyte. Undetected steroids or those detected below LLOQ were replaced by 0.5×LLOQ for statistical purposes. Statistical comparison using Mann–Whitney U test or Kruskal–Wallis test with multiple comparisons. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001. ns, non-significant.CC BY-NC · PubMed Central
Figure 2. Endometriosis is associated with altered androgen metabolism characterized by increased production of 11KT. (A) Pearson correlation matrix of key analytes in HC demonstrates strong correlation between related steroids within relevant subgroupings including A4 and T, 11OHA4 and 11KA4 as well as 11KT and 11OHT. (B) In patients with ENDO, there was a strong correlation between both classic and 11-oxygenated androgen metabolites indicative of altered metabolism. Enzyme activity based on substrate to product ratios (product/substrate) were calculated based on measured serum concentrations in healthy control women (HC) and patients diagnosed with endometriosis (ENDO). The ratios required for sequential production of 11KT were assessed including CYP11B1 (C, D), HSD11B2 (E, F), and AKR1C3 (G, H). The ratios of 11OHA4/A4 (C), 11OHT/T (D), and 11KA4/11OHA4 (E) were significantly decreased in ENDO compared with HC. In contrast, the ratios of 11KT/11OHT (F), 11OHT/11OHA4 (G), and 11KT/11KA4 (H) were significantly increased in ENDO compared with HC. Collectively, these metabolism changes are associated with increased production of 11KT (I). Statistical comparison using Mann–Whitney U test. *P<0.05, ****P<0.0001.
Figure 2. Endometriosis is associated with altered androgen metabolism characterized by increased production of 11KT. (A) Pearson correlation matrix of key analytes in HC demonstrates strong correlation between related steroids within relevant subgroupings including A4 and T, 11OHA4 and 11KA4 as well as 11KT and 11OHT. (B) In patients with ENDO, there was a strong correlation between both classic and 11-oxygenated androgen metabolites indicative of altered metabolism. Enzyme activity based on substrate to product ratios (product/substrate) were calculated based on measured serum concentrations in healthy control women (HC) and patients diagnosed with endometriosis (ENDO). The ratios required for sequential production of 11KT were assessed including CYP11B1 (C, D), HSD11B2 (E, F), and AKR1C3 (G, H). The ratios of 11OHA4/A4 (C), 11OHT/T (D), and 11KA4/11OHA4 (E) were significantly decreased in ENDO compared with HC. In contrast, the ratios of 11KT/11OHT (F), 11OHT/11OHA4 (G), and 11KT/11KA4 (H) were significantly increased in ENDO compared with HC. Collectively, these metabolism changes are associated with increased production of 11KT (I). Statistical comparison using Mann–Whitney U test. *P<0.05, ****P<0.0001.CC BY-NC · PubMed Central
Figure 3. Androgen concentrations can be used to robustly discriminate between HC and ENDO. ROC curve analysis of serum analyte concentrations (A-C) and ratios (D-F) was assessed (G). Robust discrimination between HC and ENDO was observed for single analytes; T (AUC 0.8152; P<0.001), 11KA4 (AUC 0.8145; P<0.001) and 11KT (AUC 0.8219; P<0.001), and for each ratio; 11OHA4/A4 (AUC 0.8556; P<0.001), 11OHT/11OHA4 (AUC 0.817; P<0.001), and 11KT/11KA4 (AUC 0.9676; P<0.001). Sensitivity, specificity, and likelihood ratio were summarized, and the ratio of 11KT/11KA4 provided the most robust discrimination between HC and ENDO (G). (H) Multiple logistic regression modelling was used to fit a predictive model using androgen concentrations, age and BMI as dependent variables, and diagnosed endometriosis as the outcome variable. (I) ROC curve analysis of model demonstrated excellent discrimination between HC and ENDO with AUC of 0.99 (P<0.0001, CI 0.9794-1.000). (J) The predictive power of the model was calculated based on observed vs predicted outcomes. The negative predictive power of the model was 92.86%, and the positive predictive power was 96.84%. Statistical comparison was performed by Mann–Whitney U test.
Figure 3. Androgen concentrations can be used to robustly discriminate between HC and ENDO. ROC curve analysis of serum analyte concentrations (A-C) and ratios (D-F) was assessed (G). Robust discrimination between HC and ENDO was observed for single analytes; T (AUC 0.8152; P<0.001), 11KA4 (AUC 0.8145; P<0.001) and 11KT (AUC 0.8219; P<0.001), and for each ratio; 11OHA4/A4 (AUC 0.8556; P<0.001), 11OHT/11OHA4 (AUC 0.817; P<0.001), and 11KT/11KA4 (AUC 0.9676; P<0.001). Sensitivity, specificity, and likelihood ratio were summarized, and the ratio of 11KT/11KA4 provided the most robust discrimination between HC and ENDO (G). (H) Multiple logistic regression modelling was used to fit a predictive model using androgen concentrations, age and BMI as dependent variables, and diagnosed endometriosis as the outcome variable. (I) ROC curve analysis of model demonstrated excellent discrimination between HC and ENDO with AUC of 0.99 (P<0.0001, CI 0.9794-1.000). (J) The predictive power of the model was calculated based on observed vs predicted outcomes. The negative predictive power of the model was 92.86%, and the positive predictive power was 96.84%. Statistical comparison was performed by Mann–Whitney U test.CC BY-NC · PubMed Central
Figure 4. A refined predictive model accurately identifies endometriosis in a blinded dataset. The whole data set was partitioned into train and validation groups. The training set contained dependent and outcome variables for HC (n=21) and ENDO (n=21), and the validation set contained dependent variables but was blinded to outcome variable (n=138). Multiple logistic regression was used to fit a refined predictive model using BMI, 11OHA4, 11KA4, and 11KT as dependent variables and diagnosed endometriosis as the outcome variable (A, B). Samples with missing data were excluded as part of the regression analysis. (C) ROC curve analysis of the model demonstrated excellent discrimination between HC and ENDO with AUC of 0.965 (P<0.0001, CI 0.9124-1.000). The estimated negative predictive power of the model was 94.74% with a positive predictive power of 95.24%. (A, D) The actual performance of the model was assessed using the remaining data with outcome blinded (validation set). (E) The sensitivity for ENDO was 95.65% with accurate prediction observed in all disease stage stratifications; including grouped minimal/mild (Stage I + II), moderate/severe (Stage III + IV), or by individual rASRM Stage (I-IV).
Figure 4. A refined predictive model accurately identifies endometriosis in a blinded dataset. The whole data set was partitioned into train and validation groups. The training set contained dependent and outcome variables for HC (n=21) and ENDO (n=21), and the validation set contained dependent variables but was blinded to outcome variable (n=138). Multiple logistic regression was used to fit a refined predictive model using BMI, 11OHA4, 11KA4, and 11KT as dependent variables and diagnosed endometriosis as the outcome variable (A, B). Samples with missing data were excluded as part of the regression analysis. (C) ROC curve analysis of the model demonstrated excellent discrimination between HC and ENDO with AUC of 0.965 (P<0.0001, CI 0.9124-1.000). The estimated negative predictive power of the model was 94.74% with a positive predictive power of 95.24%. (A, D) The actual performance of the model was assessed using the remaining data with outcome blinded (validation set). (E) The sensitivity for ENDO was 95.65% with accurate prediction observed in all disease stage stratifications; including grouped minimal/mild (Stage I + II), moderate/severe (Stage III + IV), or by individual rASRM Stage (I-IV).CC BY-NC · PubMed Central

Verification

Claims the paper makes

15 Valid · 1 Not valid · 2 Not checked · 98 Own results and interpretations

72 more claims · 3 with their cited sources checked

Create a free account to see all 116 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 20
  • It may state two separate claims as one. 22
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

5 of 6 · the rest aren’t loaded

1 more finding

Create a free account to see every finding of this check.

See all findings — free account

Citations

Cites

Show all 33 references

Metadata

Authors
Simitsidellis, I., Ainslie, R. J., Taylor, A. E., Gilligan, L. C., Shaheen, F., Blanke, S., Anderson, C., Hapangama, D., Arlt, W., Horne, A. W., Saunders, P. T. K., & Gibson, D. A.
Affiliations
  • MRC Centre for Reproductive Health (GB)
  • Metabolism and Systems Science, School of Medicine and Health, University of Birmingham , Birmingham B15 2TT ,
  • University of Birmingham (GB)
  • University of Glasgow (GB)
  • University of Liverpool (GB)
  • MRC London Institute of Medical Sciences (GB)
Corresponding author
Gibson, Douglas A
Venue
European Journal of Endocrinology
Published
2026-07-01
Volume
195
Issue
1
Pages
22-34
ISSN
  • 0804-4643 (ISSN-L)
  • 1479-683X
OpenAlex
W7167626821
Cited by
1
References
30
Citations by year
2026: 1
FWCI
5.30
Type
journal article
Language
en
Open access
Locations
  • European Journal of Endocrinology (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by-nc)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion, cc-by)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion, cc-by-nc)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
  • Spiral (Imperial College London) (submittedVersion, cc-by-nc)
Funders
  • Wellcome Trust (220656/Z/20/Z, 209492/Z/17/Z)
  • Medical Research Council (MRC/IAA/002, MR/N024524/1, MC_UP_1605/15)
  • Institute for Regeneration and Repair Innovators award
  • MRC
  • NIHR
  • CSO
  • Wellbeing of Women
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords
endometriosis, adrenal androgen production, 11-ketotestosterone, 11-oxygenated androgens, diagnostic biomarkers
MeSH terms
Adrenal Glands, Adult, Androgens, Endometriosis, Female, Humans, Testosterone, Biomarkers, Case-Control Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Steroid hormone profiling reveals altered adrenal androgen production in endometriosis. https://app.cochat.ai/papers/10.1093/ejendo/lvag109
The paper
Simitsidellis, I., Ainslie, R. J., Taylor, A. E., Gilligan, L. C., Shaheen, F., Blanke, S., Anderson, C., Hapangama, D., Arlt, W., Horne, A. W., Saunders, P. T. K., & Gibson, D. A. (2026). Steroid hormone profiling reveals altered adrenal androgen production in endometriosis. European Journal of Endocrinology. https://doi.org/10.1093/ejendo/lvag109

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.